Afuco™ Anti-Human TNF ADCC Therapeutic Antibody (AVX-470), ADCC Enhanced
Anti-TNF ADCC Enhanced Antibody (AVX-470) is an ADCC enhanced antibody produced by our Afuco™ platform. AVX-470 is a novel polyclonal antibody specific for human TNF used for Inflammatory bowel disease (IBD). IBD is a chronic inflammatory disease of the gastrointestinal tract, which is currently treated with injected monoclonal antibodies specific for tumor necrosis factor (TNF).
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-601CL |
| Pricing | Inquiry |
| Host | Cow |
| Target | TNF |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | Neut, FuncS |
| Storage | ≤1 year at -20°C. |